Profile | GDS5420 / 217497_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1349.4 | 84 |
GSM1296119 | B_lesional_pre-dose | 398.81 | 64 |
GSM1296076 | C_lesional_pre-dose | 264.69 | 58 |
GSM1296092 | D_lesional_pre-dose | 443.31 | 66 |
GSM1296103 | E_lesional_pre-dose | 1307.42 | 83 |
GSM1296078 | F_lesional_pre-dose | 162.07 | 51 |
GSM1296107 | G_lesional_pre-dose | 212.64 | 53 |
GSM1296109 | H_lesional_pre-dose | 630.07 | 71 |
GSM1296080 | I_lesional_pre-dose | 1070.05 | 80 |
GSM1296090 | J_lesional_pre-dose | 353.04 | 63 |
GSM1296074 | K_lesional_pre-dose | 634.92 | 72 |
GSM1296111 | L_lesional_pre-dose | 380.42 | 63 |
GSM1296099 | M_lesional_pre-dose | 756.38 | 74 |
GSM1296086 | O_lesional_pre-dose | 418.73 | 65 |
GSM1296117 | P_lesional_pre-dose | 623.94 | 72 |
GSM1296113 | Q_lesional_pre-dose | 756.24 | 75 |
GSM1296096 | R_lesional_pre-dose | 916.71 | 78 |
GSM1296105 | S_lesional_pre-dose | 315.46 | 59 |
GSM1296098 | T_lesional_pre-dose | 1932.7 | 89 |
GSM1296101 | U_lesional_pre-dose | 980.24 | 79 |
GSM1296121 | V_lesional_pre-dose | 307.87 | 59 |
GSM1296088 | W_lesional_pre-dose | 369.52 | 63 |
GSM1296082 | X_lesional_pre-dose | 377.29 | 64 |
GSM1296115 | Y_lesional_pre-dose | 531.29 | 69 |
GSM1296084 | Z_lesional_pre-dose | 206.95 | 53 |
GSM1296072 | B_lesional_day8 | 167.61 | 48 |
GSM1296069 | L_lesional_day8 | 421.98 | 64 |
GSM1296071 | P_lesional_day8 | 238.28 | 53 |
GSM1296070 | Y_lesional_day8 | 294.8 | 58 |
GSM1296073 | V_lesional_day8 | 356.07 | 62 |
GSM1296034 | A_lesional_day15 | 1171.44 | 82 |
GSM1296041 | G_lesional_day15 | 266.07 | 57 |
GSM1296035 | R_lesional_day15 | 1312.83 | 83 |
GSM1296038 | U_lesional_day15 | 376.98 | 63 |
GSM1296047 | B_lesional_day15 | 229.77 | 54 |
GSM1296039 | E_lesional_day15 | 899.98 | 78 |
GSM1296042 | H_lesional_day15 | 233.05 | 54 |
GSM1296043 | L_lesional_day15 | 281.59 | 57 |
GSM1296037 | M_lesional_day15 | 435.49 | 65 |
GSM1296046 | P_lesional_day15 | 205.39 | 51 |
GSM1296044 | Q_lesional_day15 | 241.55 | 54 |
GSM1296045 | Y_lesional_day15 | 190.62 | 50 |
GSM1296025 | C_lesional_day15 | 218.12 | 54 |
GSM1296033 | D_lesional_day15 | 303.19 | 59 |
GSM1296027 | I_lesional_day15 | 185.34 | 53 |
GSM1296032 | J_lesional_day15 | 220.81 | 54 |
GSM1296024 | K_lesional_day15 | 553.53 | 69 |
GSM1296031 | W_lesional_day15 | 262.63 | 56 |
GSM1296028 | X_lesional_day15 | 156.2 | 49 |
GSM1296029 | Z_lesional_day15 | 274.92 | 57 |
GSM1296026 | F_lesional_day15 | 364.45 | 63 |
GSM1296030 | O_lesional_day15 | 335.75 | 62 |
GSM1296040 | S_lesional_day15 | 529.27 | 68 |
GSM1296036 | T_lesional_day15 | 1687.68 | 88 |
GSM1296048 | V_lesional_day15 | 419.08 | 65 |
GSM1296059 | A_lesional_day43 | 1011.57 | 79 |
GSM1296066 | G_lesional_day43 | 197.1 | 51 |
GSM1296060 | R_lesional_day43 | 986.41 | 79 |
GSM1296063 | U_lesional_day43 | 414.33 | 65 |
GSM1296064 | E_lesional_day43 | 611.14 | 71 |
GSM1296067 | H_lesional_day43 | 237.7 | 54 |
GSM1296062 | M_lesional_day43 | 1429.41 | 85 |
GSM1296068 | Q_lesional_day43 | 167.17 | 47 |
GSM1296050 | C_lesional_day43 | 110.75 | 43 |
GSM1296057 | D_lesional_day43 | 202.82 | 52 |
GSM1296052 | I_lesional_day43 | 102.97 | 44 |
GSM1296054 | J_lesional_day43 | 220.58 | 53 |
GSM1296049 | K_lesional_day43 | 280.78 | 58 |
GSM1296055 | W_lesional_day43 | 179.96 | 50 |
GSM1296053 | X_lesional_day43 | 242.34 | 55 |
GSM1296058 | Z_lesional_day43 | 212.09 | 54 |
GSM1296051 | F_lesional_day43 | 206.84 | 54 |
GSM1296056 | O_lesional_day43 | 778.31 | 75 |
GSM1296065 | S_lesional_day43 | 163.03 | 49 |
GSM1296061 | T_lesional_day43 | 2079.81 | 90 |
GSM1296095 | A_non-lesional_pre-dose | 146.86 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 165.95 | 48 |
GSM1296077 | C_non-lesional_pre-dose | 64.11 | 35 |
GSM1296093 | D_non-lesional_pre-dose | 320.22 | 59 |
GSM1296104 | E_non-lesional_pre-dose | 227.81 | 54 |
GSM1296079 | F_non-lesional_pre-dose | 59.61 | 34 |
GSM1296108 | G_non-lesional_pre-dose | 97.83 | 39 |
GSM1296110 | H_non-lesional_pre-dose | 162.35 | 47 |
GSM1296081 | I_non-lesional_pre-dose | 263.52 | 58 |
GSM1296091 | J_non-lesional_pre-dose | 52.91 | 33 |
GSM1296075 | K_non-lesional_pre-dose | 102.82 | 43 |
GSM1296112 | L_non-lesional_pre-dose | 157.31 | 46 |
GSM1296100 | M_non-lesional_pre-dose | 357.61 | 61 |
GSM1296087 | O_non-lesional_pre-dose | 52.96 | 34 |
GSM1296118 | P_non-lesional_pre-dose | 145.55 | 45 |
GSM1296114 | Q_non-lesional_pre-dose | 468.65 | 66 |
GSM1296097 | R_non-lesional_pre-dose | 130.07 | 45 |
GSM1296106 | S_non-lesional_pre-dose | 171.1 | 49 |
GSM1296102 | U_non-lesional_pre-dose | 399.35 | 63 |
GSM1296122 | V_non-lesional_pre-dose | 155.74 | 47 |
GSM1296089 | W_non-lesional_pre-dose | 137.21 | 45 |
GSM1296083 | X_non-lesional_pre-dose | 431.21 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 156.2 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 97.93 | 41 |